University of California, Irvine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Irvine sits in the top decile of US sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count).
University of California, Irvine: 368 sponsored US clinical trials, 74 recruiting.
University of California, Irvine sponsors 368 registered US clinical trials on ClinicalTrials.gov, 74 of them currently recruiting, and 228 completed. 27 of these trials are in Phase 3-4 (later-stage) and 92 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cancer, with 6 trials.
Top-decile sponsor footprint
University of California, Irvine ranks in the top decile of sponsors by registered trial count (#96 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
228 of 258 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
368 total, page 6 of 8
Photo-Plethysmographic Camera to Monitor Heart Rate, Respiration Rate and Oxygen Saturation in Infants
NCT00989859
Use of Hypothermia During Robotic Prostatectomy
NCT00915031
Association Between Smoking, Brain Activity, Genes, and ADHD
NCT00915798
Comparison of Motor and Sensory Response With Interstim Stimulation
NCT00943904
Trial on the Effect of Optically Modified Fiber Mattress Covers on Sleep Disturbances in Patients With Chronic Back Pain
NCT00969540
Addition of Pudendal Blocks to Pelvic Floor Physical Therapy for the Treatment of Pelvic Floor Tension Myalgia
NCT00928564
Trial of Continuous Versus Cyclic Stimulation in Interstim Therapy
NCT00928499
Ischemic Conditioning (Delay Phenomenon) in Colorectal Surgery
NCT00887497
Minimally Invasive Holmium:YAG Laser Blepharoplasty
NCT00842764
Robot-Assisted Hand Motor Therapy for Subjects With Hemiparetic Stroke
NCT01244243
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
NCT00830466
A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With Lurasidone
NCT01979679
The Investigation of a Fluorescence/Elastic Scattering Spectroscopy (F-ESS) Device for Oral Tissue Characterization
NCT00764569
Chart Review of Those Who Have Had Open, Laparoscopic, Ureteroscopic, or Percutaneous Surgery
NCT00395564
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
NCT00800722
Vascular Reactivity in Metabolic Syndrome and Diabetic Patients Using Diffuse Optical Spectroscopy
NCT00793481
Incidence of Antibiotic Resistant E.Coli in Patients Undergoing Repeat Prostate Biopsy
NCT00915213
Optimizing Photodynamic Therapy of Cutaneous Neoplastic Diseases Via Structured Illumination and Real-time Dosimetry.
NCT00784108
Tissue Donation for Myoblast Culture
NCT01119820
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
NCT00578721
Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients
NCT00762398
Perceived Barriers to Exercise in Individuals Living With Spinal Cord Injury
NCT00786786
Immunologic Abnormalities, Chronic Inflammation and Oxidative Stress in Chronic Kidney Disease
NCT00793806
Cardiac CT's Role in Asymptomatic Patients With Diabetes and Metabolic Syndrome
NCT01564485
A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
NCT00633516
Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy
NCT00581061
Femoral Arterial Access With Ultrasound Trial
NCT00667381
Study to Determine if There Are Specific Clinical Factors to Determine Stent Encrustation
NCT00581178
Lower Urinary Tract and Sexual Function in Women Following Surgery for Colorectal Disorders
NCT00667550
Assessment and Determination of Chemotherapy Resistance in Newly-Diagnosed or First Relapse Leukemia Patients
NCT00631059
Adjunct Sedatives in Endoscopic Ultrasound (EUS) and Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures
NCT00937924
PET-CT Scan Method to Monitor Pancreatic B-Cell Loss in Diabetes Mellitus
NCT00633763
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
NCT00618657
Safety Study of Nicotinamide to Treat Alzheimer's Disease
NCT00580931
Combined Anticholinergic Medication and Sacral Neuromodulation to Treat Refractory Overactive Bladder
NCT01047046
Characteristics Predictive of Pessary Success
NCT01123213
3-D Endoanal Ultrasound: Normative Anatomy of the Anal Sphincter in Nulliparous Females
NCT01123109
Treatment of Vascular Lesions With a Tandem 532/1064 nm Laser
NCT00585338
A Randomized Comparison Study of Aquacel Ag and Glucan II as Donor Site Dressings
NCT00581217
Impact of Antenatal Betamethasone on Plasma Glucose Levels
NCT00585676
A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients
NCT00598936
A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers
NCT00598819
Is the Cough Stress Test Equivalent to the 24 Hour Pad Test in the Assessment of Stress Incontinence?
NCT01123096
Composite Graft Use in Abdominal Sacrocolpopexy Reduces Erosion Rates
NCT00581412
Stress, Immunity and Cervical Cancer: Biobehavioral Outcomes
NCT00496106
Carbohydrate Study, Chronic SCI
NCT00786435
Inflammatory Bowel Disease Research Registry
NCT00574028
Incidence of Ocular Antibodies in Patients With Sturge - Weber Syndrome (SWS)
NCT00610402
Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer
NCT00570700
Glucose Study, Spinal Cord Injury
NCT00786604
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 46 |
| Phase 2 | 46 |
| Phase 3 | 6 |
| Phase 4 | 21 |
Therapeutic Areas
What is open in the University of California, Irvine pipeline
74 recruiting of 368 indexed (20% open); 228 completed (62%).
Phase mix: 27 late (III/IV) vs 92 early (I/II) (early-phase heavy).
Top condition: Cancer (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Irvine: open-pipeline peers nationwide
Peers matched on 368 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of California, Irvine sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 368 trials (± recruiting share)
- Northwell Health · 370 trials · 22% recruiting
- UNC Lineberger Comprehensive Cancer Center · 366 trials · 22% recruiting
- Roswell Park Cancer Institute · 365 trials · 16% recruiting
- New York State Psychiatric Institute · 364 trials · 3% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of Miami · 20% recruiting · 721 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of California, Irvine page
368 registered trials is a research-attention snapshot, not an endorsement of University of California, Irvine or any single study.
- 74 of University of California, Irvine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Cancer is the condition University of California, Irvine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Irvine pipeline card: 368 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.